Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 43 min 27 sec ago

Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs

Tue, 08/19/2014 - 14:26
Companies Reach Agreement to Develop a New and Differentiated FFR Guidewire and Next Generation Boston Scientific Rotablator™ RotaWire™ MARLBOROUGH, Mass. and NAGOYA, Japan, Aug. 19, 2014 -- (Healthcare Sales & Marketing Network) -- Boston Scientific C...
Devices, Interventional Cardiology
Boston Scientific, ASAHI INTECC, fractional flow reserve, FFR wires

Rosetta Genomics Expands Management Team With Appointment of Douglas Sites as Executive Vice President of Sales and Marketing

Mon, 08/18/2014 - 13:32
Brings Extensive Track Record in Leading Commercial Teams and Driving Revenues in MicroRNA, Oncology and Thyroid Diagnostics PRINCETON, NJ and REHOVOT, ISRAEL--(Healthcare Sales & Marketing Network) - Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading deve...
Diagnostics, Personnel
Rosetta Genomics

Mark S. Levine Joins Minerva Neurosciences as VP and General Counsel

Mon, 08/18/2014 - 13:28
CAMBRIDGE, Mass., Aug. 18, 2014 -- (Healthcare Sales & Marketing Network) -- Minerva Neurosciences (NERV), a leader in the development of new therapies to treat neuropsychiatric diseases and disorders, today announced that Mark S. Levine has been appointe...
Biopharmaceuticals, Neurology, Personnel
Minerva Neurosciences

ResMed's New AirSense 10 CPAP and APAP Devices Deliver Superior Patient Comfort and Cost-Saving Efficiency for Healthcare Providers

Mon, 08/18/2014 - 13:23
Intelligent AirSense 10 Flow Generators Promote Precise, Personalized Patient Care SAN DIEGO, Aug. 18, 2014 -- (Healthcare Sales & Marketing Network) -- ResMed (RMD), the industry leader in patient-comfort innovation, today introduced its new AirSense...
ResMed, AirSense, positive-airway pressure

Ampio Announces Very Positive Results of the Open Label Portion of the Multiple Intra-articular Injections Study of Ampion(TM) in Patients with Osteoarthritis of the Knee at Week Six of the Trial

Mon, 08/18/2014 - 13:18
ENGLEWOOD, Colo., Aug. 18, 2014 -- (Healthcare Sales & Marketing Network) -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced the 6 weeks results of the open label portion of the multiple injections of Ampion™ into the knees of patients (n=7) ...
Biopharmaceuticals, Orthopaedic
Ampio Pharmaceuticals, Ampion , osteoarthritis

Boston Therapeutics Appoints Noted Diabetes Specialist Jaime A. Davidson, M.D. to Its Medical Advisory Board

Mon, 08/18/2014 - 13:11
MANCHESTER, NH--(Healthcare Sales & Marketing Network) - Boston Therapeutics, Inc. (OTCQB: BTHE), a developer of complex carbohydrate therapeutics to treat diabetes, has appointed noted diabetes specialist Jaime A. Davidson, M.D. to its Medical Advisory Bo...
Biopharmaceuticals, Endocrinology, Personnel
Boston Therapeutics

Cook Medical Enrolls First Patient in Zilver(R) PTX(R) Drug Eluting Peripheral Stent Clinical Study in China

Fri, 08/15/2014 - 12:54
BLOOMINGTON, Ind.--(Healthcare Sales & Marketing Network)--Cook Medical has enrolled the first patient in the clinical study in China of its Zilver® PTX® Drug Eluting Peripheral Stent. The case was performed by one of the study’s principal investig...
Devices, Interventional
Cook Medical, Zilver PTX, drug eluting stent, peripheral artery disease

Innovus Pharma and Consortia Health Initiate a Nationwide Marketing and Sales Campaign to U.S. Gynecologists for Zestra(R), Clinically Proven for the Enhancement of Female Arousal Desire and Satisfaction

Fri, 08/15/2014 - 12:48
SAN DIEGO, Aug. 15, 2014 -- (Healthcare Sales & Marketing Network) -- Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company) (INNV) a leader in over-the-counter ("OTC") and consumer care products fo...
Innovus Pharmaceuticals, Consortia Health, Zestra

FDA Approves Genentech’s Avastin Plus Chemotherapy for Treatment of Advanced Cervical Cancer

Thu, 08/14/2014 - 21:19
Avastin is the first biologic medicine approved in combination with chemotherapy to help women with this type of cancer live longer than with chemotherapy alone SOUTH SAN FRANCISCO, Calif.--(Healthcare Sales & Marketing Network)--Genentech, a member of ...
Biopharmaceuticals, Oncology, FDA
Genentech, Roche Group, Avastin, bevacizumab, Cervical Cancer

Vermillion Announces Additions to Commercial Management Team

Thu, 08/14/2014 - 13:33
AUSTIN, Texas, Aug. 14, 2014 -- (Healthcare Sales & Marketing Network) -- Vermillion, Inc. (VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, has appointed David Jansen as Vice President of Marketing. In addition...
Diagnostics, Personnel

Aurora Spine Appoints Regional Vice President of Sales

Thu, 08/14/2014 - 13:29
CARLSBAD, CALIFORNIA--(Healthcare Sales & Marketing Network) - Aurora Spine Corporation (TSX VENTURE:ASG) announced today the appointment of Joe Bocchino as Regional Vice President of Sales for the Western United States. Mr. Bocchino will be responsible fo...
Devices, Orthopaedic, Neurosurgery, Personnel
Aurora Spine, spine surgery

Ligand Signs Multi-Program Captisol(R) License Agreement with Avion Pharmaceuticals

Thu, 08/14/2014 - 13:24
Adds Four Additional Fully-Funded Programs to Partnered Portfolio SAN DIEGO--(Healthcare Sales & Marketing Network)--Ligand Pharmaceuticals Incorporated (LGND) announces the signing of a commercial license agreement with Avion Pharmaceuticals, LLC for t...
Biopharmaceuticals, Licensing
Ligand Pharmaceuticals, Avion Pharmaceuticals, Captisol

Inotek Pharmaceuticals Names David P. Southwell as President and Chief Executive Officer

Wed, 08/13/2014 - 20:41
LEXINGTON, Mass.--(Healthcare Sales & Marketing Network)--Inotek Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on ophthalmology, today announced that David. P. Southwell has been named President and Chief Executive Officer. Mr. ...
Biopharmaceuticals, Ophthalmology, Personnel
Inotek Pharmaceuticals, Trabodenoson

Tarsa Therapeutics Secures $10 Million And Adds Industry Veteran Daniel Soland As A Director

Wed, 08/13/2014 - 20:30
PHILADELPHIA, Aug. 13, 2014 -- (Healthcare Sales & Marketing Network) -- Tarsa Therapeutics, Inc. today announced that it has secured a $10 million senior credit facility from Oxford Finance LLC and Square 1 Bank. The company intends to use the proceeds t...
Biopharmaceuticals, Venture Capital, Personnel
Tarsa Therapeutics, Ostora , calcitonin

Castle Biosciences Announces $11.8 Million Financing

Wed, 08/13/2014 - 20:23
Led by New Investor HealthQuest Capital Funds to Expand Clinical Availability of Cutaneous Melanoma Gene Expression Profile Test FRIENDSWOOD, Texas--(Healthcare Sales & Marketing Network)--Castle Biosciences Inc., a cancer-focused molecular diagnosti...
Diagnostics, Venture Capital
Castle Biosciences, DecisionDx-Melanoma

Seventh Sense Biosystems Closes $16 Million Series B Financing

Wed, 08/13/2014 - 11:39
New Investors Siemens, Novartis and LabCorp® Join Polaris Partners and Flagship Ventures to Fund Development and Launch of Patented Touch Activated Phlebotomy (TAP™) Blood Collection and Testing Platforms CAMBRIDGE, Mass.--(Healthcare Sales & Market...
Devices, Diagnostics, Venture Capital
Seventh Sense Biosystems, Touch Activated Phlebotomy

Cutera Receives FDA 510(k) Clearance for enlighten(TM)

Tue, 08/12/2014 - 12:57
First and Only FDA-Cleared Dual Wavelength and Dual Pulse Duration Laser Featuring Picosecond Technology BRISBANE, Calif., Aug. 12, 2014 -- (Healthcare Sales & Marketing Network) -- Cutera, Inc. (CUTR), a leading provider of laser, light and other energ...
Devices, Dermatology, FDA
Cutera, enlighten laser, picosecond

AMAG Pharmaceuticals Appoints Robert Blood as Vice President of Legal Affairs and Chief Compliance Officer

Tue, 08/12/2014 - 12:53
WALTHAM, Mass., Aug. 12, 2014 -- (Healthcare Sales & Marketing Network) -- AMAG Pharmaceuticals, Inc. (AMAG) today announced the appointment of Robert Blood, Esq. as vice president of legal affairs and chief compliance officer. Mr. Blood comes to AMAG with...
Biopharmaceuticals, Personnel
AMAG Pharmaceuticals

FDA Approves Exact Sciences' Cologuard(R); First and Only Stool DNA Noninvasive Colorectal Cancer Screening Test

Tue, 08/12/2014 - 12:50
First time in history a technology receives FDA approval and proposed national coverage by CMS on the same day Screening test detects 92% of colorectal cancer MADISON, Wis., Aug. 12, 2014 -- (Healthcare Sales & Marketing Network) -- Exact Sciences C...
Diagnostics, Oncology, FDA
Exact Sciences, Cologuard, colorectal cancer

Lithera Announces Company Name Change to Neothetics, Inc.

Tue, 08/12/2014 - 12:43
SAN DIEGO, Aug. 12, 2014 -- (Healthcare Sales & Marketing Network) -- Lithera, Inc., announced today that it has changed its name to Neothetics, Inc. The new name strengthens the company's positioning as a clinical-stage, specialty pharmaceutical company d...
Biopharmaceuticals, Dermatology
Neothetics, Lithera , aesthetic

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong